An MRC Cleanroom facility, built for long-term partner Biogeneric Pharma (BGP) based in Cairo Egypt, is being recognised as a tech transfer recipient by the WHO (World Health Organisation).
BGP will be the first technology transfer recipient of mRNA vaccine hub in Egypt for Africa & low- and middle-income countries. This huge accomplishment is the fruit of both process and facility excellence. Achieved through a focus on quality and consistency.
The groundbreaking project aims to assist low- and middle-income countries in manufacturing mRNA vaccines on a scale and according to international standards, with the aim of ending much of the reliance of African countries on vaccine manufacturers outside the continent.
The company received a WHO delegation headed by Mariângela Simão Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, who was impressed by the facility and its technical capabilities from both asset and personnel perspectives.
"We hope that Biogeneric enjoys a long and successful business in this field and we look forward to further collaborations," MRC stated.
